Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Dujrudee Chinwong, Jayanton Patumanond, Surarong Chinwong, Khanchai Siriwattana, Siriluck Gunaparn, John Joseph Hall & Arintaya Phrommintikul. (2015) Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency. Therapeutics and Clinical Risk Management 11, pages 127-136.
Read now
Read now
Kevin Jameson, Qiaoyi Zhang, Changgeng Zhao, Dena Rosen Ramey, Andrew M. Tershakovec, Stephen W. Gutkin & Elizabeth Marrett. (2014) Total and low-density lipoprotein cholesterol in high-risk patients treated with atorvastatin monotherapy in the United Kingdom: analysis of a primary-care database. Current Medical Research and Opinion 30:4, pages 655-665.
Read now
Read now
Laurent Laforest, Baishali M Ambegaonkar, Thierry Souchet, Vasilisa Sazonov & Eric Van Ganse. (2012) Mixed dyslipidemias in primary care patients in France. Vascular Health and Risk Management 8, pages 247-254.
Read now
Read now
Naila Goldenberg & Charles Glueck. (2009) Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk. Vascular Health and Risk Management 5, pages 369-376.
Read now
Read now
Alberico L. Catapano. (2009) Perspectives on low-density lipoprotein cholesterol goal achievement. Current Medical Research and Opinion 25:2, pages 431-447.
Read now
Read now
Edith M. Heintjes, Mark W. Hirsch, Michiel W. van der Linden, John C. O‘Donnell, John C. O‘Donnell, Anton F. Stalenhoef & Ron M. C. Herings. (2008) LDL-C reductions and goal attainment among naive statin users in the Netherlands: real life results. Current Medical Research and Opinion 24:8, pages 2241-2250.
Read now
Read now
Hyo-Soo Kim, Yangfeng Wu, Shing-Jong Lin, Chaicharn Deerochanawong, Robaayah Zambahari, Liancheng Zhao, Qiaoyi Zhang & Peter Yan. (2008) Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study. Current Medical Research and Opinion 24:7, pages 1951-1963.
Read now
Read now
Srinivasan Rajagopalan, Evo Alemao, Liz Finch & Don Yin. (2007) Impact of new Joint British Societies’ (JBS 2) guidelines on prevention of cardiovascular disease: evaluation of serum total cholesterol goal achievement in UK clinical practice. Current Medical Research and Opinion 23:8, pages 2027-2034.
Read now
Read now
Laszlo Mark, Gyozo Dani, Özseb Fazekas, Olga Szüle, Hajnalka Kovacs & Andras Katona. (2007) Effects of ezetimibe on lipids and lipoproteins in patients with hypercholesterolemia and different apolipoprotein E genotypes. Current Medical Research and Opinion 23:7, pages 1541-1548.
Read now
Read now
Articles from other publishers (56)
Zoltán Jancsó, Orsolya Csenteri, Gergő József Szőllősi, Péter Vajer & Péter Andréka. (2022) Cardiovascular risk management: the success of target level achievement in high- and very high-risk patients in Hungary. BMC Primary Care 23:1.
Crossref
Crossref
Yannick Degboé, Richard Koch, Laurent Zabraniecki, Bénédicte Jamard, Guillaume Couture, Jean Bernard Ruidavets, Jean Ferrieres, Adeline Ruyssen-Witrand & Arnaud Constantin. (2022) Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study. Frontiers in Medicine 9.
Crossref
Crossref
Pietro Scicchitano, Michele Milo, Rosanna Mallamaci, Micaela De Palo, Pasquale Caldarola, Francesco Massari, Domenico Gabrielli, Furio Colivicchi & Marco Matteo Ciccone. (2021) Inclisiran in lipid management: A Literature overview and future perspectives. Biomedicine & Pharmacotherapy 143, pages 112227.
Crossref
Crossref
Sheng-Na Han, Wei-Hong Yang, Jian-Jian Yin, Hai-Long Tao & Li-Rong Zhang. (2019) Drug Treatment of Hyperlipidemia in Chinese Patients: Focus on the Use of Simvastatin and Ezetimibe Alone and in Combination. American Journal of Cardiovascular Drugs 19:3, pages 237-247.
Crossref
Crossref
Zhijian Huang, Qian Li, Weixiang Ye, Qiang Zhang & Xiuyan Li. (2019) Efficacy and Safety of Ezetimibe in Combination with Atorvastatin for Acute Coronary Syndrome Patients Accompanied with Type 2 Diabetes: A Single-Center, Non-randomized Cohort Study. Chemical and Pharmaceutical Bulletin 67:5, pages 419-425.
Crossref
Crossref
Yun Wang, Bryan Ping Yen Yan, Brian Tomlinson, Michael Bruce Nichol & Vivian Wing Yan Lee. (2018) Clinical and Economic Analysis of Lipid Goal Attainments in Chinese Patients with Acute Coronary Syndrome Who Received Post-Percutaneous Coronary Intervention. Journal of Atherosclerosis and Thrombosis 25:12, pages 1255-1273.
Crossref
Crossref
Yun Wang, Bryan P. Yan, Michael B. Nichol, Brian Tomlinson & Vivian W.Y. Lee. (2017) Real-world study of low-density lipoprotein cholesterol levels and cardiovascular outcomes in Chinese: A retrospective cohort study in post-percutaneous coronary intervention acute coronary syndrome patients. International Journal of Cardiology 249, pages 18-24.
Crossref
Crossref
Soubra Lama, Domiati Souraya & Fattouh Youssef. (2017) Statin prescription strategies and atherogenic cholesterol goals attainment in Lebanese coronary artery disease patients. International Journal of Clinical Pharmacy 39:4, pages 919-926.
Crossref
Crossref
Carl Groves, Chandrashekar Shetty, Richard C Strange, Julian Waldron & Sudarshan Ramachandran. (2017) A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels. Postgraduate Medical Journal 93:1098, pages 205-208.
Crossref
Crossref
Michał Holecki, Gabriela Handzlik-Orlik, Agnieszka Almgren-Rachtan, Jan Duława & Jerzy Chudek. (2017) The decreased achievement of therapeutic goal in lipid lowering therapy in obese and diabetic patients in Poland. Pharmacological Reports 69:1, pages 6-12.
Crossref
Crossref
Kornelia Kotseva, Dirk De Bacquer, Guy De Backer, Lars Rydén, Catriona Jennings, Viveca Gyberg, Ana Abreu, Carlos Aguiar, Almudena C Conde, Kairat Davletov, Mirza Dilic, Maryna Dolzhenko, Dan Gaita, Borislav Georgiev, Nina Gotcheva, Nebojsa Lalic, Aleksandras Laucevicius, Dragan Lovic, Silvia Mancas, Davor Miličić, Raphael Oganov, Andrzej Pajak, Nana Pogosova, Željko Reiner, Dusko Vulic, David Wood & on behalf of the EUROASPIRE investi. (2016) Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. European Journal of Preventive Cardiology 23:18, pages 2007-2018.
Crossref
Crossref
S. Unniachan, L. D. Bash, W. Khovidhunkit, R. Z. T. Sri, E. Vicaldo, C. RectoIIII & B. M. Ambegaonkar. (2014) Prevalence of lipid abnormalities and attainment of normal lipid levels among patients with dyslipidaemia: a pooled analysis of observational studies from five Asian countries. International Journal of Clinical Practice 68:8, pages 1010-1019.
Crossref
Crossref
Diego Ardig?Olga Vaccaro, Franco Cavalot, Albarosa Angela Rivellese, Laura Franzini, Roberto Miccoli, Lidia Patti, Massimo Boemi, Mariella Trovati & Ivana Zavaroni. (2012) Effectiveness of treat-to-target strategy for LDL-cholesterol control in type 2 diabetes: post-hoc analysis of data from the MIND.IT study. European Journal of Preventive Cardiology 21:4, pages 456-463.
Crossref
Crossref
Varda Shalev, Inbal Goldshtein, Yair Halpern & Gabriel Chodick. (2014) Association Between Persistence with Statin Therapy and Reduction in Low-Density Lipoprotein Cholesterol Level: Analysis of Real-Life Data from Community Settings. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:1, pages 1-8.
Crossref
Crossref
Silvia Rollefstad, Tore K Kvien, Ingar Holme, Anne S Eirheim, Terje R Pedersen & Anne Grete P Semb. (2013) Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic. Annals of the Rheumatic Diseases 72:12, pages 1968-1974.
Crossref
Crossref
Baishali M. Ambegaonkar, Lori D. Bash, Diana R. Chirovsky, Kevin Jameson, Susan Grant, Gonzalo Nocea, Billie Pettersson & Vasilisa Sazonov. (2013) Attainment of normal lipid levels among high cardiovascular risk patients: Pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada. European Journal of Internal Medicine 24:7, pages 656-663.
Crossref
Crossref
Endre Szigethy, Zoltán Jancsó, Csaba Móczár, István Ilyés, Eszter Kovács, László Róbert Kolozsvári & Imre Rurik. (2013) Primary care of patients with high cardiovascular riskErstversorgung von Patienten mit hohem kardiovaskulärem Risiko. Wiener klinische Wochenschrift 125:13-14, pages 371-380.
Crossref
Crossref
Tomasz Tomasik, Adam Windak, Bohumil Seifert, Janko Kersnik, Violetta Kijowska & Katarzyna Dubas. (2012) Lipid-Lowering Pharmacotherapy in Central and Eastern European Countries in Cardiovascular Prevention. Journal of Cardiovascular Pharmacology and Therapeutics 18:3, pages 234-242.
Crossref
Crossref
Calvin W ChinF GaoTT LeRS Tan. (2013) Lipid Goal Attainment and Prescription Behavior in Asian Patients with Acute Coronary Syndromes: Experience from a Tertiary Hospital. Clinical Medicine Insights: Cardiology 7, pages CMC.S11488.
Crossref
Crossref
Alfred Penfornis, Alain Baleydier, Thierry Clavel & Sylvie Picard. (2012) LDL-cholesterol target values and actual values in patients with type 2 diabetes (T2D) uncontrolled on oral antidiabetic monotherapy: The lipid results of the French ESCALADE survey. Annales d'Endocrinologie 73:6, pages 503-509.
Crossref
Crossref
Maria Bo?entowicz-Wikarek, Piotr Koce?ak, Mike Smertka, Magdalena Olszanecka-Glinianowicz & Jerzy Chudek. (2012) Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis ? guidelines vs. reality. Pharmacological Reports 64:2, pages 377-385.
Crossref
Crossref
V. Breuil, B. Cortet, F.-E. Cotté, B. Arnould, C. Dias-Barbosa, A.-F. Gaudin, A. Regnault, A. Roborel de Climens & E. Legrand. (2011) Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. Osteoporosis International 23:2, pages 445-455.
Crossref
Crossref
Antonio Pérez, Cintia González Blanco, Miguel Ángel Hernández-Presa & José Chaves. (2011) Estrategia de tratamiento de la dislipemia y consecución de objetivos en la población española con diabetes tipo 2 sin enfermedad cardiovascular. Endocrinología y Nutrición 58:6, pages 283-290.
Crossref
Crossref
Tomasz Tomasik, Jacek Jozwiak, Adam Windak, Katarzyna Rygiel, Miroslaw Mastej, W Henry Smithson, Nigel Mathers, Maciej Tomaszewski, Bernhard M Kaess, Andrzej Tykarski, Ewa Konduracka, Wladyslaw Grzeszczak & Witold Lukas. (2011) Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study. European Journal of Cardiovascular Prevention & Rehabilitation 18:2, pages 287-296.
Crossref
Crossref
Antonio Pérez, Cintia González Blanco, Miguel Ángel Hernández-Presa & José Chaves. (2011) Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease. Endocrinología y Nutrición (English Edition) 58:6, pages 283-290.
Crossref
Crossref
Komelia Kotseva, David Wood, Guy De Backer, Dirk De Bacquer, Kalevi Pyörälä, Željko Reiner & Ulrich Keil. (2010) EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. European Journal of Cardiovascular Prevention & Rehabilitation 17:5, pages 530-540.
Crossref
Crossref
John Reckless, Glenn Davies, Kaan Tunceli, X. Henry Hu & Philippe Brudi. (2010) Projected Cost-Effectiveness of Ezetimibe/Simvastatin Compared with Doubling the Statin Dose in the United Kingdom: Findings from the INFORCE Study. Value in Health 13:6, pages 726-734.
Crossref
Crossref
Marisa Gallego, Rosario Palacios, Julián Olalla, Francisco Orihuela, Juan Roldán, Jesús Santos & Mariela Grana. (2010) Colesterol ligado a lipoproteínas de baja densidad en una serie de pacientes con infección por el virus de la inmunodeficiencia humana. Medicina Clínica 135:5, pages 202-204.
Crossref
Crossref
J. David SpenceDaniel G. Hackam. (2010) Treating Arteries Instead of Risk Factors. Stroke 41:6, pages 1193-1199.
Crossref
Crossref
Mikyung KimJihye SukHyunjung KimHyesuk JungTaeik KimJeonghyun Park. (2010) Post-Prandial Lipid Levels for Assessing Target Goal Achievement in Type 2 Diabetic Patients Taking Statin. Journal of Korean Medical Science 25:3, pages 387.
Crossref
Crossref
Teresa Arrobas, Antonio Barco, Miguel Ángel Rico, Reyes de la Iglesia, Ana Isabel Oribe, Carmen Cruz & Fernando Fabiani. (2010) Influencia de la concentración de la lipoproteína(a) en la consecución de objetivos terapéuticos de colesterol LDL en pacientes de alto riesgo cardiovascular. Importancia del colesterol LDL corregido. Clínica e Investigación en Arteriosclerosis 22:1, pages 7-14.
Crossref
Crossref
F.-E. Cotté, P. Fardellone, F. Mercier, A.-F. Gaudin & C. Roux. (2009) Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. Osteoporosis International 21:1, pages 145-155.
Crossref
Crossref
László Márk & András Katona. (2009) From lipid target values to JUPITER study. Importance of the achievement of lipid levels specified by the guidelines and deficiencies in the present practice. Orvosi Hetilap 150:44, pages 2012-2018.
Crossref
Crossref
Manuel ?ngel G?mez Marcos, Emiliano Rodr?guez S?nchez, Emilio Ramos Delgado, Carmen Fern?ndez Alonso, Angel Luis Montejo G?nzalez & Luis Garc?a Ortiz. (2009) Permanencia del efecto de una intervenci?n de mejora de calidad en el seguimiento prolongado de pacientes hipertensos (CICLO-RISK STUDY). Atenci?n Primaria 41:7, pages 371-378.
Crossref
Crossref
Kornelia Kotseva, David Wood, Guy De Backer, Dirk De Bacquer, Kalevi Pyörälä & Ulrich Keil. (2009) EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. European Journal of Cardiovascular Prevention & Rehabilitation 16:2, pages 121-137.
Crossref
Crossref
Adnan K. Chhatriwalla, Stephen J. Nicholls, Thomas H. Wang, Kathy Wolski, Ilke Sipahi, Tim Crowe, Paul Schoenhagen, Samir Kapadia, E. Murat Tuzcu & Steven E. Nissen. (2009) Low Levels of Low-Density Lipoprotein Cholesterol and Blood Pressure and Progression of Coronary Atherosclerosis. Journal of the American College of Cardiology 53:13, pages 1110-1115.
Crossref
Crossref
Otto Mayer, Jaroslav Šimon, Jan Bruthans, Markéta Galovcová, Jana Hrbková & Jiří Bělohoubek. (2009) The usual dosage regimen of statins and adherence to target LDL-cholesterol levels by Czech patients in the secondary prevention of coronary heart disease. Cor et Vasa 51:2, pages 92-96.
Crossref
Crossref
Laurent Laforest, Thierry Souchet, Philippe Moulin, Cécile Ritleng, Gaëlle Desamericq, Philippe Le Jeunne, Marie-Sophie Schwalm & Eric Van Ganse. (2009) Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs. Archives of Cardiovascular Diseases 102:1, pages 43-50.
Crossref
Crossref
György Paragh, Gyula Pados, László Márk, István Karádi, Mária Audikovszky, Károly Zámolyi & László Romics. (2008) To What Extent are National Cardiovascular Disease Preventive Guidelines Accomplished in Hungary? The Goal Attainment Program (GAP). Hungarian Medical Journal 2:4, pages 593-602.
Crossref
Crossref
François-Emery Cotté, Florence Mercier & Gérard De Pouvourville. (2008) Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: A retrospective case—control analysis. Clinical Therapeutics 30:12, pages 2410-2422.
Crossref
Crossref
László Márk, Győző Dani, Zoltán Kiss & András Katona. (2008) A change of attitude in lipidology, achievement of target levels. What comes next?. Orvosi Hetilap 149:37, pages 1731-1736.
Crossref
Crossref
Kenneth K.C. Lee, Vivian W.Y. Lee, Wai Kwong Chan, Benjamin S.C. Lee, Agnes C.Y. Chong, Jasper C.L. Wong, Don Yin, Evo Alemao & Brian Tomlinson. (2008) Cholesterol Goal Attainment in Patients with Coronary Heart Disease and Elevated Coronary Risk: Results of the Hong Kong Hospital Audit Study. Value in Health 11, pages S91-S98.
Crossref
Crossref
Adam P. Levine, Dimitri P. MikhailidisTessa Moross, Karen Benson & Mayur Gor. (2008) Achieving Vascular Risk Factor Targets: A Survey of a London General Practice. Angiology 59:1, pages 36-46.
Crossref
Crossref
Nuria Plana, Catherine Nicolle, Raimon Ferre, Jordi Camps, Rosa Cos, Jesus Villoria & Luis Masana. (2008) Plant sterol-enriched fermented milk enhances the attainment of LDL-cholesterol goal in hypercholesterolemic subjects. European Journal of Nutrition 47:1, pages 32-39.
Crossref
Crossref
Gustavo C. Rodríguez-Roca, Francisco J. Alonso-Moreno, Vivencio Barrios, José L. Llisterri, Salvador Lou, Arantxa Matalí & José R. Banegas. (2007) Características de la presión arterial en una población dislipémica española asistida en atención primaria. Estudio LIPICAP-PA. Revista Española de Cardiología 60:8, pages 825-832.
Crossref
Crossref
P. Lindgren, F. Borgström, J. Stålhammar, E. Alemao & L. Jönsson. (2007) Determinants of cholesterol goal attainment at 12 months in patients with hypercholesterolaemia not at consensus goal after 3 months of treatment with lipid-lowering drugs. International Journal of Clinical Practice 61:8, pages 1410-1414.
Crossref
Crossref
Anthony S. Wierzbicki. (2007) Targets - who needs them? Success with statin therapies. International Journal of Clinical Practice 61:8, pages 1239-1242.
Crossref
Crossref
Eric Van Ganse, Laurent Laforest, Thomas Burke, Hemant Phatak & Thierry Souchet. (2007) Mixed Dyslipidemia Among Patients Using Lipid-Lowering Therapy in French General Practice: An Observational Study. Clinical Therapeutics 29:8, pages 1671-1681.
Crossref
Crossref
L. R. Erhardt & F. D. R. Hobbs. (2007) A global survey of physicians’ perceptions on cholesterol management: the From The Heart study. International Journal of Clinical Practice 61:7, pages 1078-1085.
Crossref
Crossref
Gy??rgy Paragh, L??szlo M??rk, K??roly Z??molyi, Gyula Pados & P??ter Ofner. (2007) Lipid-Modifying Therapy and Attainment of Cholesterol Goals in Hungary. Clinical Drug Investigation 27:9, pages 647-660.
Crossref
Crossref
Savina Nodari, Patrizia Rocca, Alberto Saporetti, Luca Bettari, Anna Lucia Foresti, Elena Tanghetti, Marco Metra & Livio Dei Cas. (2018) The Combination of Ezetimibe and Statin: A New Treatment for Hypercholesterolemia. Heart International 3:1-2, pages 182618680700300.
Crossref
Crossref
Gustavo C. Rodríguez-Roca, Francisco J. Alonso-Moreno, Vivencio Barrios, José L. Llisterri, Salvador Lou, Arantxa Matalí & José R. Banegas. (2007) Blood Pressure Findings in Spanish Dyslipidemic Primary-Care Patients. LIPICAP–PA Study. Revista Española de Cardiología (English Edition) 60:8, pages 825-832.
Crossref
Crossref
Zo Rakotoniaina, Pascal Guerard, Frederic Lirussi, Françoise Goirand, Luc Rochette, Monique Dumas & Marc Bardou. (2006) The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin. Naunyn-Schmiedeberg's Archives of Pharmacology 374:3, pages 195-206.
Crossref
Crossref
Jos? R. Gonz?lez-Juanatey, Eduardo Alegr?a-Ezquerra, Joaqu?n Aznar-Costa, Vicente Bertomeu-Mart?nez, Josep Franch-Nadal & Jos? L. Palma-G?miz. (2006) Conocimiento y aplicaci?n de las gu?as de pr?ctica cl?nica sobre riesgo cardiovascular en las consultas generales y especializadas. Revista Espa?ola de Cardiolog?a 59:8, pages 801-806.
Crossref
Crossref
Yu A Karpov & A D Deev. (2006) Rossiyskaya programma LIDER: otsenka izmeneniya kachestva zhizni boL'nykh Ishemicheskoy bolezn'yu serDtsa na fonE teRapii liprimarom. Systemic Hypertension 3:2, pages 26-30.
Crossref
Crossref
Mary Ellen Kitler. (2005) European Society of Cardiology. International Journal of Pharmaceutical Medicine 19:4, pages 239-242.
Crossref
Crossref